• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

揭示 YWHAH:克服结直肠癌中 CD8 T 细胞耗竭的潜在治疗靶点。

Unveiling YWHAH: A potential therapeutic target for overcoming CD8 T cell exhaustion in colorectal cancer.

机构信息

Department of General Surgery, The Second Affiliated Hospital of Soochow University, Suzhou 215004, Jiangsu Province, China; Department of General Surgery, The Second Affiliated Hospital of Xuzhou Medical University, Xuzhou 221000, Jiangsu Province, China.

Department of General Surgery, The Second Affiliated Hospital of Xuzhou Medical University, Xuzhou 221000, Jiangsu Province, China.

出版信息

Int Immunopharmacol. 2024 Jun 30;135:112317. doi: 10.1016/j.intimp.2024.112317. Epub 2024 May 25.

DOI:10.1016/j.intimp.2024.112317
PMID:38796965
Abstract

Colorectal cancer (CRC) is a significant global health challenge, with increasing rates of incidence and mortality. Despite advancements in immunotherapy, resistance, particularly due to T cell exhaustion, remains a major hurdle. This study explores the role of YWHAH, mediated by N4-acetylcytidine (ac4C) modification, in CRC progression and its impact on CD8 T cell exhaustion. Analysis of five paired CRC patient tissue samples using acetylated RNA immunoprecipitation and sequencing (acRIP-seq)identified ac4C-modified mRNAs. Functional assays, including cell culture, transfection, qRT-PCR, and immune assays, investigated the influence of YWHAH expression on CRC advancement. Bioinformatics analysis of TCGA data assessed the correlation between YWHAH and immune responses, as well as checkpoint inhibitors. Flow cytometry and Immunohistochemistry validated these findings, complemented by a co-culture experiment involving CD8 T cells and CRC cell lines (LOVO and HCT116). acRIP-seq revealed YWHAH as a potential driver of CRC progression, exhibiting ac4C modification-mediated stability and upregulation. High YWHAH levels correlated with adverse outcomes and immune evasion in CRC patients, showing strong associations with immune checkpoint proteins and modest correlations with CD8 T cell infiltration. Co-culture experiments demonstrated YWHAH-induced CD8 T cell exhaustion, characterized by decreased proliferation and increased exhaustion markers. NAT10-mediated ac4C modification enhanced YWHAH stability in CRC. The involvement of YWHAH in CD8 + T cell exhaustion suggests its potential as a therapeutic target and prognostic marker in CRC immunotherapy, highlighting the intricate interplay between epitranscriptomic modifications, the tumor microenvironment, and immune responses in CRC progression.

摘要

结直肠癌(CRC)是一个重大的全球健康挑战,其发病率和死亡率呈上升趋势。尽管免疫疗法取得了进展,但耐药性,尤其是由于 T 细胞耗竭,仍然是一个主要障碍。本研究探讨了 YWHAH 通过 N4-乙酰胞苷(ac4C)修饰在 CRC 进展中的作用及其对 CD8 T 细胞耗竭的影响。使用乙酰化 RNA 免疫沉淀和测序(acRIP-seq)分析了五个配对的 CRC 患者组织样本,鉴定了 ac4C 修饰的 mRNAs。功能分析,包括细胞培养、转染、qRT-PCR 和免疫分析,研究了 YWHAH 表达对 CRC 进展的影响。TCGA 数据分析评估了 YWHAH 与免疫反应以及检查点抑制剂之间的相关性。流式细胞术和免疫组织化学验证了这些发现,并通过涉及 CD8 T 细胞和 CRC 细胞系(LOVO 和 HCT116)的共培养实验进行了补充。acRIP-seq 显示 YWHAH 是 CRC 进展的潜在驱动因素,表现出 ac4C 修饰介导的稳定性和上调。高 YWHAH 水平与 CRC 患者的不良结局和免疫逃避相关,与免疫检查点蛋白具有强烈关联,与 CD8 T 细胞浸润具有适度相关性。共培养实验表明 YWHAH 诱导 CD8 T 细胞耗竭,表现为增殖减少和耗竭标志物增加。NAT10 介导的 ac4C 修饰增强了 CRC 中 YWHAH 的稳定性。YWHAH 参与 CD8 + T 细胞耗竭表明其在 CRC 免疫治疗中作为治疗靶点和预后标志物的潜力,突出了 CRC 进展中表转录组修饰、肿瘤微环境和免疫反应之间的复杂相互作用。

相似文献

1
Unveiling YWHAH: A potential therapeutic target for overcoming CD8 T cell exhaustion in colorectal cancer.揭示 YWHAH:克服结直肠癌中 CD8 T 细胞耗竭的潜在治疗靶点。
Int Immunopharmacol. 2024 Jun 30;135:112317. doi: 10.1016/j.intimp.2024.112317. Epub 2024 May 25.
2
Elucidating the role of T-cell exhaustion-related genes in colorectal cancer: a single-cell bioinformatics perspective.从单细胞生物信息学角度阐明 T 细胞耗竭相关基因在结直肠癌中的作用。
Funct Integr Genomics. 2023 Aug 2;23(3):259. doi: 10.1007/s10142-023-01188-9.
3
A CLRN3-Based CD8 T-Related Gene Signature Predicts Prognosis and Immunotherapy Response in Colorectal Cancer.CLRN3 为基础的 CD8 T 细胞相关基因标志物预测结直肠癌的预后和免疫治疗反应。
Biomolecules. 2024 Jul 24;14(8):891. doi: 10.3390/biom14080891.
4
Acetylcysteine synergizes PD-1 blockers against colorectal cancer progression by promoting TCF1PD1CD8 T cell differentiation.乙酰半胱氨酸通过促进 TCF1-PD1-CD8 T 细胞分化协同 PD-1 抑制剂抑制结直肠癌进展。
Cell Commun Signal. 2024 Oct 17;22(1):503. doi: 10.1186/s12964-024-01848-8.
5
Colorectal Cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall Survival.结直肠癌相关的免疫耗竭涉及 T 和 B 淋巴细胞以及常规 NK 细胞,与总生存期更短相关。
Front Immunol. 2021 Dec 16;12:778329. doi: 10.3389/fimmu.2021.778329. eCollection 2021.
6
N-acetyltransferase 10 facilitates tumorigenesis of diffuse large B-cell lymphoma by regulating AMPK/mTOR signalling through N4-acetylcytidine modification of SLC30A9.N-乙酰基转移酶 10 通过 SLC30A9 的 N4-乙酰胞嘧啶修饰调控 AMPK/mTOR 信号通路促进弥漫性大 B 细胞淋巴瘤的发生。
Clin Transl Med. 2024 Jul;14(7):e1747. doi: 10.1002/ctm2.1747.
7
Cholesterol induction in CD8 T cell exhaustion in colorectal cancer via the regulation of endoplasmic reticulum-mitochondria contact sites.通过调节内质网-线粒体接触位点诱导结直肠癌 CD8+T 细胞耗竭中的胆固醇。
Cancer Immunol Immunother. 2023 Dec;72(12):4441-4456. doi: 10.1007/s00262-023-03555-8. Epub 2023 Nov 3.
8
Long Noncoding RNA KCNQ1OT1 is a Prognostic Biomarker and mediates CD8 T cell exhaustion by regulating CD155 Expression in Colorectal Cancer.长链非编码 RNA KCNQ1OT1 是结直肠癌的预后生物标志物,通过调节 CD155 的表达来介导 CD8 T 细胞衰竭。
Int J Biol Sci. 2021 Apr 22;17(7):1757-1768. doi: 10.7150/ijbs.59001. eCollection 2021.
9
NAT10-mediated mRNA N4-acetylcytidine modification of MDR1 and BCRP promotes breast cancer progression.NAT10 介导的 MDR1 和 BCRP mRNA N4-乙酰胞嘧啶修饰促进乳腺癌进展。
Thorac Cancer. 2024 Apr;15(10):820-829. doi: 10.1111/1759-7714.15262. Epub 2024 Feb 26.
10
NAT10-mediated mRNA N4-acetylcytidine modification promotes bladder cancer progression.NAT10 介导的 mRNA N4-乙酰胞嘧啶修饰促进膀胱癌进展。
Clin Transl Med. 2022 May;12(5):e738. doi: 10.1002/ctm2.738.

引用本文的文献

1
Emerging role of N-acetyltransferase 10 in diseases: RNA ac4C modification and beyond.N-乙酰转移酶10在疾病中的新作用:RNA的ac4C修饰及其他
Mol Biomed. 2025 Jul 1;6(1):46. doi: 10.1186/s43556-025-00286-3.
2
NAT10 promotes radiotherapy resistance in non-small cell lung cancer by regulating KPNB1-mediated PD-L1 nuclear translocation.NAT10通过调节KPNB1介导的PD-L1核转位促进非小细胞肺癌的放疗抵抗。
Open Life Sci. 2025 Mar 18;20(1):20251065. doi: 10.1515/biol-2025-1065. eCollection 2025.
3
Acetyltransferase NAT10 promotes an immunosuppressive microenvironment by modulating CD8 T cell activity in prostate cancer.
乙酰转移酶NAT10通过调节前列腺癌中CD8 T细胞的活性来促进免疫抑制微环境。
Mol Biomed. 2024 Dec 9;5(1):67. doi: 10.1186/s43556-024-00228-5.
4
Emerging Role of NAT10 as ac4C Writer in Inflammatory Diseases: Mechanisms and Therapeutic Applications.NAT10作为ac4C书写酶在炎症性疾病中的新作用:机制与治疗应用
Curr Drug Targets. 2025;26(4):282-294. doi: 10.2174/0113894501346709241202110834.